Author

L. Wanderlingh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Amoresano· 1 shared A. Carissimo· 1 shared D. Medina· 1 shared F. Pane· 1 shared M. Mariniello· 1 shared R. La Montagna· 1 shared R. Petruzzelli· 1 shared R. Polishchuk· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Amoresano

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Synthetic lethality screening identifies FDA-approved drugs that overcome ATP7B-mediated tolerance of tumor cells to cisplatin

M. Mariniello, R. Petruzzelli, L. Wanderlingh, R. La Montagna, A. Carissimo, F. Pane, A. Amoresano, D. Medina, R. Polishchuk

The paper identifies FDA-approved drugs that overcome ATP7B-mediated cisplatin resistance in ovarian cancer cells through synthetic lethality screening.

bioRxiv · Jul 3, 2019Cancer Biology